1-8 of 8
Ivan Sloma, PharmD,PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

NUP98-HOXA9 -Initiates Molecular and Biologic Features of Disease Progression in a Humanized Model of CML

Ivan Sloma, PharmD, PhD, Philip Beer, PhD FRCPath, MRCP, Christophe Desterke, PhD, Elizabeth Bulaeva, Misha Bilenky, Michelle Moksa, Kamini Raghuram, Cedric Brimacombe, Karen Lambie, Ali G Turhan, MD PhD, Orianne Wagner-Ballon, MD PhD, Philippe Gaulard, MD PhD, R. Keith Humphries, MD PhD, Martin Hirst, PhD BS, Connie J. Eaves, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4139.
https://doi.org/10.1182/blood-2019-127839
Published: 2019
Journal Articles

The Absolute Count of Circulating, Classical, CD14 ++ /CD16 - Monocytes Is a Poor Prognosis Marker in Chronic Myelomonocytic Leukemia (CMML)

Matthieu Jestin, Sihem Tarfi, PharmD, Bouchra Badaoui, PharmD, Nicolas Freynet, PharmD, Ivan Sloma, PharmD,PhD, Margot Morabito, Sébastien Maury, MD PhD, Pierre Fenaux, MD PhD, Eric Solary, MD PhD, Dorothée Selimoglu-Buet, PhD, Orianne Wagner Ballon, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4242.
https://doi.org/10.1182/blood-2019-121794
Published: 2019
Journal Articles

Aryl Hydrocarbon Receptor (AhR) Pathway Directly Controls Hematopoietic Proliferation in Chronic Myeloid Leukemia (CML) and Its Inhibition Allows Massive Expansion of Leukemic Progenitors and Stem Cells

Melanie Gentil, MD, Patricia Hugues, Gladys Telliam, Ivan Sloma, PharmD,PhD, Seda Baykal, Jerome Artus, PhD, Agnes Guerci, MD, Hyacinthe Johnson Ansa, Adlen Foudi, PhD, Annelise Bennaceur-Griscelli, MD PhD, Ali G Turhan, MD PhD
Journal: Blood
Blood (2015) 126 (23): 4013.
https://doi.org/10.1182/blood.V126.23.4013.4013
Published: 2015
Journal Articles

A Bio-Integrative Approach Identifies an Inflammatory Signature in Chronic Myeloid Leukemia (CML) Stem Cells That Is Highly Perturbed in CML Blast Crisis and Involves REL transcription Factor

Christophe Desterke, PhD, Ludovic Marie-Sainte, Amine Sbitti, PhD, Ali Naama, Annelise Bennaceur-Griscelli, MD PhD, Ali G Turhan, MD PhD, Ivan Sloma, PharmD,PhD
Journal: Blood
Blood (2015) 126 (23): 4017.
https://doi.org/10.1182/blood.V126.23.4017.4017
Published: 2015
Journal Articles

Whole Genome Sequencing Of Chronic Myeloid Leukemia (CML)-Derived Induced Pluripotent Stem Cells (iPSC) Reveals Faithful Genocopying Of Highly Mutated Primary Leukemic Cells

Ivan Sloma, PharmD, PhD, Maria Teresa Mitjavila-Garcia, PhD, Olivier Feraud, Noufissa Oudrhiri, Lucie Tosca, PharmD, PhD, Sanaa El Marsafy, MD, PhD, Emilie Gobbo, Dominique Divers, Alexis Proust, Frank Griscelli, PharmD PhD, Gerard Tachdjian, MD, PhD, Marco A. Marra, PhD, Connie J Eaves, PhD, Annelise Bennaceur-Griscelli, MD, PhD, Ali G Turhan, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 514.
https://doi.org/10.1182/blood.V122.21.514.514
Published: 2013
Journal Articles

Evaluation of Leukemic Stem Cell Persistence in Chronic Myeloid Leukemia (CML) Patients in Complete Molecular Remission Induced by First Line TKI Therapies

Jean-Claude Chomel, PharmD, PhD, Marie Laure Bonnet, Nathalie Sorel, PhD, Ivan Sloma, PharmD, PhD, Alexis Proust, Annelise Bennaceur-Griscelli, MD, PhD, Delphine Rea, MD, PhD, Madalina Uzunov, M.D., Laurence Legros, MD, PhD, Shanti Ame, MD, Anne Marfaing-Koka, Agnès Guerci, MD, Philippe Rousselot, MD, PhD, Ali G Turhan, M.D., PhD
Journal: Blood
Blood (2012) 120 (21): 3726.
https://doi.org/10.1182/blood.V120.21.3726.3726
Published: 2012
Journal Articles

A Single Chronic Myeloid Leukemia (CML) Stem Cell Harboring Both BCR-ABL and JAK2-V617F Mutation Modeled by Induced Pluripotency

Ivan Sloma, PharmD, PhD, Maria Teresa Mitjavila-Garcia, PhD, Olivier Feraud, Lucie Tosca, PharmD, PhD, Sanaa El Marsafy, MD, PhD, Emilie Gobbo, Dominique Divers, Alexis Proust, Marie Laure Bonnet, Frank Griscelli, PharmD PhD, Gerard Tachdjian, MD, PhD, Annelise Bennaceur-Griscelli, MD, PhD, Ali G Turhan, M.D., PhD
Journal: Blood
Blood (2012) 120 (21): 3728.
https://doi.org/10.1182/blood.V120.21.3728.3728
Published: 2012
Journal Articles

Longterm Serial Transplantability of BCR-ABL+ Chronic Phase CML Cells Is Predicted by a 6-Week LTC-IC Assay.

Ivan Sloma, PharmD, PhD, Philip A Beer, BM, MRCP, MRCPath, Kyi Min Saw, Matthiew Chan, Karen Lambie, Bobby Johnston, Xiaoyan Jiang, MD, PhD, Connie J. Eaves, PhD
Journal: Blood
Blood (2012) 120 (21): 2770.
https://doi.org/10.1182/blood.V120.21.2770.2770
Published: 2012